The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | IMS session highlights: clinical challenges in multiple myeloma
Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center, San Antonio, Texas, shares her highlights from the session on clinical challenges in multiple myeloma that was held at this year’s IMS meeting, commenting on the management of toxicities associated with immunotherapies, the importance of better diagnosing amyloidosis, and learning how to better use and sequence available immunotherapeutics. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
